Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS1 | P29475 | 2/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.44 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 3/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14643881 | 1.00 | NOS1 (0.50) | NOS1KCNH2SMN1; SMN2ALDH1A1GABRA5 | |
| SCHEMBL3828155 | 1.00 | NOS1 (0.50) | NOS1KCNH2SMN1; SMN2ALDH1A1GABRA5 | |
| SCHEMBL11588307 | 1.00 | NOS1 (0.50) | NOS1KCNH2SMN1; SMN2ALDH1A1GABRA5 | |
| SCHEMBL44477 | 0.98 | NOS1 (0.51) | NOS1KCNH2SMN1; SMN2ALDH1A1GABRA5 | |
| Ammonia Solution, Strong SCHEMBL28007740 | 0.96 | NOS1 (0.50) | NOS1KCNH2SMN1; SMN2ALDH1A1GABRA5 | |
| SCHEMBL2373929 | 0.92 | NOS1 (0.53) | NOS1SMN1; SMN2ALDH1A1GABRA5GABRB2 | |
| Acetamide SCHEMBL9942181 | 0.89 | GABRA5 (0.50) | NOS1KCNH2SMN1; SMN2ALDH1A1GABRA5 | |
| SCHEMBL5911714 | 0.84 | — | — | |
| Pyridine SCHEMBL27812107 | 0.82 | NOS1 (0.51) | NOS1KCNH2SMN1; SMN2ALDH1A1GABRA5 | |
| SCHEMBL8937107 | 0.81 | KCNH2 (0.52) | KCNH2ALDH1A1RAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5162360-A | Treating hypercholesterolemia and atherosclerosis; ACAT acyl-coenzyme A:-cholesterol acyltransferase | WARNER-LAMBERT COMPANY (US) | 1992-11-10 | — | — | US | disclosed |